Prolonged oro-facial dystonia in a 58 year old female following therapy with bupropion and St John's Wort [5]

British Journal of Clinical Pharmacology

Volumn 64, Issue 5, 2007, Pages 717-718

  Milton, James C ^a   Abdulla, Aza ^a  

^a Princess Royal University Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CARBAMAZEPINE; CHLORPHENIRAMINE; DIAZEPAM; ESTRADIOL; HYPERICUM PERFORATUM EXTRACT; MEDROXYPROGESTERONE; PROCYCLIDINE; TRIDESTRA; UNCLASSIFIED DRUG; VALPROIC ACID;

ADULT; BELL PALSY; BIOCHEMISTRY; BLOOD EXAMINATION; CASE REPORT; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; DRINKING BEHAVIOR; DYSTONIA; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; HYPERICUM PERFORATUM; HYPOTHYROIDISM; LETTER; NEUROLOGIC EXAMINATION; OROFACIAL DYSTONIA; PRIORITY JOURNAL; WILSON DISEASE;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; FEMALE; HUMANS; HYPERICUM; MIDDLE AGED; MOVEMENT DISORDERS; PHYTOTHERAPY; TREATMENT OUTCOME;

EID: 35248816835     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.02962.x     Document Type: Letter

References (7)

1. Roddy E. ABC of smoking cessation. Bupropion and other non-nicotine pharmacotherapies. BMJ 2004 328 : 509 11.
2. GlaxoSmithKline 2006 personal communication.
3. Detweiler MB, Harpold GJ. Bupropion-induced acute dystonia. Ann Pharmacother 2002 36 : 251 4.
4. Loscher W. Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochem Res 1993 18 : 485 502.
5. Foley KF, DeSanty KP, Kast RE. Bupropion. Pharmacology and therapeutic applications. Expert Rev Neurotherapeutics 2006 6 : 1249 65.
6. Gerber PE, Lynd LD. Selective serotonin-reuptake inhibitor-induced movement disorders. Ann Pharmacother 1998 32 : 692 8.
7. Fugh-Berman A, Ernst E. Herb-drug interactions. Review and assessment of report reliability. Br J Clin Pharmacol 2001 52 : 587 95.